July 2, 2026
9:54 pm

Is Now the Right Time for a Life Settlement? Market Timing Considerations

Now is generally the right time for a life settlement when three clocks align: you are 65 or older or have experienced a meaningful health change, your policy faces a real problem such as unaffordable premiums or an expiring conversion window, and you no longer need the full death benefit. Timing matters because offers are driven by your life expectancy, your policy’s cost structure, and the interest-rate environment in which institutional buyers price their bids. Waiting can raise offers in some situations and destroy them in others — most dramatically when a term policy’s conversion deadline passes or a policy lapses. According to the U.S. Government Accountability Office, settlements have historically paid several times more than cash surrender value, but only for policyholders who act while their policy still qualifies.

This guide walks through each timing factor — personal, policy-level, and market-level — so you can judge whether to move now, wait deliberately, or simply test the market without committing.

In This Article

Why Timing Matters More in Life Settlements Than in Most Financial Decisions
The Personal Clock: Age and Health Windows
The Policy Clock: Deadlines That Can Eliminate the Option Entirely
The Market Clock: Interest Rates and Institutional Capital
Signals That Now Is Likely the Right Time
Signals That Waiting — or Not Selling at All — Is the Better Call
The Cost of Waiting: A Framework for the Undecided
How to Test the Market Without Committing to a Sale
Putting It All Together: A Timing Decision Sequence
Frequently Asked Questions

Is Now the Right Time for a Life Settlement? Market Timing Considerations

Why Timing Matters More in Life Settlements Than in Most Financial Decisions

A life settlement is the sale of an existing life insurance policy to a licensed provider for a lump sum greater than the cash surrender value but less than the death benefit. Unlike selling a stock or a house, the asset being priced is not static — it is a contract whose value to a buyer changes continuously with your age, your health, your premium schedule, and the yield environment in which institutional investors operate.

Three separate clocks run at the same time:

Your personal clock. Age and health drive the life expectancy estimates that anchor every offer. As life expectancy shortens, projected value to a buyer generally rises.
Your policy’s clock. Grace periods, term conversion deadlines, cost-of-insurance increases, and cash value depletion all impose hard or soft deadlines. Some of these, once passed, permanently eliminate the option to sell.
The market’s clock. Buyers are licensed providers backed by institutional capital — pension funds, asset managers, and insurance-linked securities funds — and they price policies using discounted cash flow analysis. Prevailing interest rates and the amount of capital chasing policies shift what they can pay.

Because these clocks can point in different directions — your health may argue for waiting while your policy’s conversion window argues for acting immediately — the timing question is never answered by a single factor. The rest of this article examines each clock in turn, then shows how to weigh them together. For background on the underlying transaction, see how life settlements work from application through escrow and closing.

The Personal Clock: Age and Health Windows

Life settlement offers are anchored to life expectancy reports — typically two independent estimates prepared by specialized underwriting firms, a process that takes roughly two to six weeks. The shorter the estimated life expectancy, the fewer premium payments a buyer expects to make and the sooner the death benefit is projected to pay, so offers generally rise as life expectancy falls.

This creates a counterintuitive dynamic: from a pure pricing standpoint, an 80-year-old with health impairments usually receives a much stronger offer than a healthy 68-year-old with the same policy. Qualifying standards reflect this — providers generally look for insureds age 65 and older, though younger policyholders with significant health conditions can qualify. The details are covered in who qualifies for a life settlement.

What does this mean for timing?

A recent health change is often the single strongest timing signal. A new diagnosis, a hospitalization, or a progression of an existing condition typically shortens life expectancy estimates and can move an offer from marginal to meaningful. If your health has changed since you last explored a settlement, prior quotes are stale.
Waiting purely to age into a better offer is a gamble. Yes, each passing year generally improves pricing, all else equal. But all else is rarely equal — you must keep paying premiums while you wait, the policy may lapse, and market conditions may shift against you.
Very long life expectancies may mean no market at all. If underwriters project decades of remaining life, buyers may decline to bid. In that case, waiting is not a strategy choice; it is the only option, and the focus should shift to keeping the policy affordable in the meantime.

The Policy Clock: Deadlines That Can Eliminate the Option Entirely

The most urgent timing considerations are usually built into the policy itself. Several policy-level deadlines can permanently close the door on a settlement, and they deserve priority over every market-timing question.

Term conversion windows. Term insurance is generally sellable only if it can be converted to a permanent policy, and conversion privileges expire — often at age 70 or after a set number of policy years. Once a term conversion window closes, a policy that might have supported a six-figure settlement can become worth nothing on the secondary market. If your conversion deadline is within the next twelve months, this factor outweighs virtually everything else.

Impending lapse. A policy in its 30–31 day grace period can sometimes still be appraised and sold, but the margin for error is razor thin. Providers need time for underwriting, life expectancy reports, offers, and escrow — a process that typically runs 60 to 120 days end to end. Starting that process after you have stopped paying premiums is starting it too late.

Cash value depletion in universal life. Many universal life policies were illustrated at interest rates that never materialized. As cash value erodes and cost-of-insurance charges rise with age, required premiums can jump sharply. Selling before the policy enters a death spiral of escalating funding requirements usually produces a better outcome than selling from distress later.

In-force seasoning. Policies generally must have been in force at least two years before they can be sold, a rule rooted in state insurable-interest and anti-STOLI protections. If your policy is younger than that, the timing question answers itself: you wait.

The Market Clock: Interest Rates and Institutional Capital

Life settlement buyers are not individuals; they are licensed providers deploying institutional capital from pension funds, asset managers, and dedicated funds. These investors value the asset class because returns are driven by mortality experience rather than stock market performance — a genuinely non-correlated return stream. They price each policy with a discounted cash flow model: projected death benefit, minus projected premiums, discounted back at their required rate of return over the insured’s life expectancy.

That discounting mechanism is where interest rates enter the picture:

When prevailing rates rise, investors’ required returns rise with them, and future death benefits are discounted more heavily. Offers as a percentage of face value tend to compress.
When rates fall, the same projected cash flows are discounted more gently, and buyers can pay more while still hitting their return targets. Falling-rate environments have historically been friendlier to sellers.
Capital flows matter independently of rates. When more institutional money is allocated to the asset class, providers compete harder for a limited supply of qualifying policies, and competitive auctions push offers upward.

Here is the practical caveat: these market forces are real, but they are second-order compared with your personal and policy clocks. A one-percentage-point move in discount rates might shift an offer by a modest fraction; a health change or a missed conversion deadline can double an offer or erase it. Regulators, including the National Association of Insurance Commissioners, note that pricing varies significantly case by case. Trying to time interest-rate cycles the way traders time bond markets is not a realistic strategy for an individual policyholder — but understanding the environment helps you interpret the offers you receive, a topic explored further in how life settlement value is calculated.

Timing Factor	Typical Effect on Offer Value	How Urgent Is It?
Advancing age / shortened life expectancy	Offers generally rise as life expectancy falls	Gradual — improves with time, but only if the policy stays in force
Recent health change or new diagnosis	Can materially increase offers; makes old quotes stale	Act soon — request updated appraisals
Term conversion window closing	Offer can drop to zero once the window passes	Critical — hard deadline, start 6–12 months ahead
Policy nearing lapse / grace period	Distress timing weakens negotiating position; lapse ends the option	Critical — process takes 60–120 days
Universal life cash value depletion	Rising funding costs erode buyer economics over time	High — sell before escalating premiums set in
Falling interest rates	Buyers discount cash flows less; offers tend to improve	Low — unpredictable, second-order factor
Rising interest rates	Higher required returns compress offers	Low — not worth trying to trade around
More institutional capital entering market	Greater competition among providers lifts bids	Low — reinforces value of soliciting multiple offers

The Market Clock: Interest Rates and Institutional Capital

Signals That Now Is Likely the Right Time

No checklist can decide for you, but certain fact patterns strongly suggest that exploring the market now — rather than in a year or two — is the sensible move.

Premiums have become a genuine burden. If you are drawing down retirement savings, skipping other obligations, or borrowing against the policy just to keep it in force, the policy is consuming the resources it was meant to protect. Sellers who act before distress sets in negotiate from a stronger position than those racing a lapse date.
The original purpose of the coverage has ended. The mortgage is paid, the children are financially independent, the business that required key-person coverage has been sold, or your estate is comfortably below the federal exemption of more than $13 million per individual. A death benefit no one depends on is a candidate for repurposing.
Your health has recently changed. As discussed above, updated life expectancy reports following a diagnosis or hospitalization frequently produce materially better offers than earlier quotes.
A policy deadline is approaching. A term conversion cutoff, a scheduled premium increase, or projected cash value exhaustion within 12–24 months all argue for starting the 60–120 day process now, while every option remains open.
You have already priced the alternatives. If you have compared surrender value, reduced paid-up options, loans, and accelerated death benefits and none solves the problem, a market test is the logical next step. A structured comparison framework is laid out in is a life settlement right for you.

When several of these signals appear together, the cost of waiting — continued premiums plus the risk of a closed window — usually exceeds any plausible benefit from delay.

Signals That Waiting — or Not Selling at All — Is the Better Call

Honest timing analysis cuts both ways. There are situations where the right time is later, and situations where the right time is never.

Someone still depends on the death benefit. If a spouse, a child with special needs, or a business partner would face genuine hardship without the payout, the settlement question is premature regardless of what the market is paying. The death benefit almost always exceeds any settlement offer — typically 10–35% of face value per the GAO’s study of the market — so selling coverage your family needs is a losing trade.
You can comfortably afford the premiums. If keeping the policy causes no financial strain, holding preserves the full death benefit for your beneficiaries and keeps the settlement option available should circumstances change.
You may qualify for accelerated death benefits instead. Policyholders with a terminal or chronic illness may be able to access a portion of the death benefit directly from the insurer through a rider, often without selling the policy at all.
You rely on means-tested benefits. A lump-sum settlement counts as an asset and can interrupt Medicaid eligibility. Timing a sale without first understanding the benefit consequences can be an expensive mistake; guidance is available at Medicaid.gov and through an elder law attorney.
Your life expectancy is long and your policy is small. If offers would be marginal, the transaction costs and lost death benefit may not justify selling now. Revisit annually.

The full catalogue of disqualifying situations is covered in when not to do a life settlement.

The Cost of Waiting: A Framework for the Undecided

If you are genuinely on the fence, replace the vague question “should I wait?” with a concrete comparison of what waiting costs against what waiting might gain.

What waiting costs:

Ongoing premiums. Every additional year in force means another year of premium outlay — often tens of thousands of dollars on larger senior policies. Any improvement in a future offer must first repay that outlay before you are ahead.
Deadline risk. Conversion windows, grace periods, and cash value depletion do not negotiate. A missed deadline can take the offer from six figures to zero.
Market risk. Rising discount rates or reduced institutional capital can compress offers between now and your future sale date.
Regulatory and personal uncertainty. Your ability to manage a 60–120 day transaction, gather records, and evaluate offers is easier now than it may be later.

What waiting might gain:

Shorter life expectancy pricing. Each year of age, and any health decline, generally improves offers — but this gain is uncertain in size and arrives only if the policy is still in force and marketable.
A friendlier rate environment. Possible, but unpredictable and usually second-order.

A useful discipline: obtain real offers now, then compare the best offer against your annual premium cost. If the offer exceeds several years of premiums and no one needs the death benefit, the math of waiting rarely works. If you do proceed, remember that state law provides a rescission window of 15 to 30 days after closing, so even a completed sale includes a final reconsideration period.

How to Test the Market Without Committing to a Sale

One of the most underappreciated facts about life settlement timing is that finding out what your policy is worth costs nothing and obligates you to nothing. Requesting appraisals or soliciting offers is not selling; it is gathering the data the timing decision requires.

A low-commitment market test looks like this:

Gather your policy documents — the policy contract, the most recent annual statement, and a current in-force illustration from the insurer showing projected premiums to age 100 or beyond.
Request a preliminary appraisal. Many licensed brokers and providers will give a non-binding estimate from basic policy and health information within days, before any formal underwriting.
Authorize formal underwriting only if the estimate is meaningful. The two independent life expectancy reports take two to six weeks and require medical records authorization, but still create no obligation to sell.
Solicit multiple offers. Because providers use different mortality assumptions and return targets, bids on the identical policy can vary widely. Competitive bidding is the single most controllable driver of your final price — see how to compare life settlement offers for a structured approach.
Decide with real numbers. With an actual best offer in hand, you can compare it against surrender value, premium costs, tax consequences, and your family’s needs — a far better position than speculating about hypothetical values.

Transactions in New Jersey are governed by the New Jersey Viatical Settlements Act and overseen by the New Jersey Department of Banking and Insurance, which licenses the brokers and providers involved — verify licensing before sharing medical records with anyone.

Putting It All Together: A Timing Decision Sequence

When policyholders ask whether now is the right time, the most reliable answer comes from working through the clocks in order of urgency rather than debating market conditions in the abstract.

Step 1: Check for hard deadlines. Is a term conversion window, grace period, or cash value exhaustion date within 24 months? If yes, start the process now — the 60–120 day transaction timeline plus underwriting means the real deadline is months earlier than the calendar suggests.

Step 2: Confirm the death benefit is genuinely surplus. If anyone still depends on the coverage, stop here and explore keeping it — possibly at a reduced level.

Step 3: Assess your personal pricing window. Are you 65 or older, or younger with significant health impairments? Has your health changed since any prior quote? Fresh circumstances justify fresh appraisals.

Step 4: Price the alternatives in parallel. Surrender value, reduced paid-up conversion, policy loans, 1035 exchanges, and accelerated death benefits each solve different problems. Tax treatment differs, too — under IRS Rev. Rul. 2009-13 as modified by the 2017 tax law, settlement proceeds are taxed in three tiers, and the IRS treats amounts up to basis as tax-free, basis to cash surrender value as ordinary income, and the remainder as capital gain.

Step 5: Let real offers make the timing argument. A concrete offer converts the abstract timing debate into simple arithmetic: offer amount versus premiums saved, taxes owed, and death benefit forgone.

Timing a life settlement is less about predicting markets and more about not missing your own windows. The policyholders who fare worst are rarely those who sold in a mediocre rate environment — they are the ones who waited until the policy lapsed or the conversion deadline passed and had nothing left to sell.

Frequently Asked Questions

Do life settlement offers go up or down when interest rates rise?

Offers tend to compress when interest rates rise. Institutional buyers price policies using discounted cash flow models, and higher prevailing rates raise the returns they demand, which means future death benefits are discounted more heavily. Conversely, falling rates generally allow buyers to pay more while still meeting return targets. That said, rate effects are usually smaller than the impact of your age, health, and policy cost structure, so rate movements alone rarely justify accelerating or delaying a sale.

Will I get a bigger life settlement offer if I wait until I’m older?

Often yes, all else being equal — offers generally improve as life expectancy shortens, and each year of age moves you in that direction. But the gain is not free. You must keep paying premiums while you wait, which offsets much of the improvement, and you risk the policy lapsing, a term conversion window closing, or market conditions weakening. Waiting is most defensible when premiums are easily affordable and no policy deadline is near; it is most dangerous when either condition fails.

How long does the life settlement process take from start to finish?

Plan on roughly 60 to 120 days from application to funded closing. The two independent life expectancy reports alone typically take two to six weeks because underwriters must collect and review your medical records. After offers are negotiated and a purchase agreement is signed, funds are placed in escrow and released once the insurer confirms the ownership and beneficiary changes. This timeline is why approaching deadlines — conversion windows, grace periods — require starting months before the calendar date.

Can I find out what my policy is worth without committing to sell it?

Yes. Requesting a preliminary appraisal or soliciting offers creates no obligation to sell. Many licensed brokers and providers will give a non-binding estimate from basic policy and health details within days. Even completing formal underwriting and receiving firm offers leaves the decision entirely with you, and if you do close, state law provides a rescission window of 15 to 30 days depending on the state, during which you can unwind the sale by returning the proceeds.

Is it too late to sell my life insurance policy if it’s about to lapse?

Not necessarily, but the window is extremely tight. Policies in the standard 30–31 day grace period can sometimes still be appraised and sold, and a buyer may advance premiums to keep the policy in force during the transaction. However, because underwriting and closing normally take 60 to 120 days, sellers who start the process during a grace period have little leverage and few options if anything goes wrong. If lapse looks likely within a year, begin exploring the market immediately.

Should I sell my term policy before the conversion deadline expires?

If you no longer need the coverage and cannot afford or justify converting it yourself, the months before the conversion deadline are often your only chance to capture value. Term policies are generally marketable only while they remain convertible to permanent insurance; once the conversion privilege expires, the policy typically has no secondary-market value. Because the settlement process takes 60 to 120 days, treat a conversion deadline as arriving six to twelve months earlier than the contract date.

Does a new health diagnosis mean I should get my policy re-appraised?

Yes. Life settlement pricing is anchored to independent life expectancy reports, and a meaningful health change — a new diagnosis, hospitalization, or progression of an existing condition — typically shortens those estimates and increases what buyers will pay. Offers or estimates you received before the change are effectively stale. Re-appraisal costs nothing and does not obligate you to sell, so an updated market test after a significant health event is nearly always worth doing.

How much more than surrender value does a life settlement typically pay?

The U.S. Government Accountability Office’s study of the market (GAO-10-775) found that settlements have typically paid policyholders several times more than surrendering — commonly cited as four to eight times cash surrender value, with gross offers generally falling between 10% and 35% of the death benefit depending on age, health, and policy costs. Individual results vary widely, which is why obtaining multiple competing offers matters more than any market-timing consideration within your control.

Find out what your policy is worth — free, confidential, no obligation.

A 15-minute educational review covers your eligibility, every alternative, and a realistic view of what each path would net you.

Call (305) 209-7183 · Request a review online →

Table of Contents